The latest research study “Vascular Grafts Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global vascular graftsmarket size reached US$ 1.67 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.43 Billion by 2027, exhibiting a growth rate (CAGR) of 6.30% during 2022-2027.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/vascular-grafts-market/requestsample
Vascular grafts refer to medical devices mostly used in vascular bypass surgeries that involve reconnecting the blood vessels to direct the blood flow from one area of the body to another. They can be of various types, such as endovascular stent grafts, hemodialysis access grafts, coronary artery bypass grafts, vascular grafts for aorta disease, peripheral vascular grafts, etc. These vascular grafts prove highly effective in replacing injured veins, valves, arteries, and blood vessels, during organ transplantation or hemodialysis, vascular occlusion, aneurysms, coronary artery diseases, and kidney failure. They aid in reducing blood leakage and allow good cell invasion from the adventitia without impacting the endothelialization rate. As a result, vascular grafts find extensive applications in hospitals and ambulatory surgical centers (ASCs) across the globe.
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
Vascular Grafts Market Trends and Drivers:
The elevating incidences of chronic heart ailments and the shifting preferences toward minimally invasive (MI) procedures are primarily driving the vascular grafts market. In addition to this, the development of three-dimensional (3D) printed polymeric vascular grafts that are biodegradable and mechanically compatible with vascular tissues and support neo-tissue formation and growth is also positively influencing the global market. Furthermore, the rising utilization of prosthetic grafts and electrospun PU vascular grafts for complex vascular trauma to reduce the risk of neointimal formation is acting as another significant growth-inducing factor. Besides this, the growing geriatric population, the inflating investments to improve healthcare infrastructure, especially in the developing countries, and the introduction of advanced next-generation tissue-engineered graft materials are expected to augment the vascular grafts market over the forecasted period.
Vascular Grafts Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Abbott Laboratories
- B. Braun SE (B. Braun Holding GmbH & Co. KG)
- Dickinson and Company
- Cook Group Incorporated
- CryoLife Inc.
- Getinge AB
- Heat Medical Europe BV
- LeMaitre Vascular
- Medtronic plc
- Terumo Corporation
- W. L. Gore & Associates Inc.The report has segmented the market on the basis of product, raw material, application and end user.
Breakup by Product:
- Endovascular Stent Grafts
- Hemodialysis Access Grafts
- Coronary Artery By-Pass Grafts
- Vascular Grafts for Aorta Disease
- Peripheral Vascular Grafts
Breakup by Raw Material:
- Polytetrafluoroethylene (PTFE)
Breakup by Application:
- Cardiac Aneurysm
- Kidney Failure
- Vascular Occlusion
- Coronary Artery Disease
Breakup by End User:
- Ambulatory Surgical Centers (ASCs)
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Raw Material, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abbott Laboratories, B. Braun SE (B. Braun Holding GmbH & Co. KG), Becton, Dickinson and Company, Cook Group Incorporated, Cordis, CryoLife Inc., Getinge AB, Heat Medical Europe BV, LeMaitre Vascular, Medtronic plc, Terumo Corporation and W. L. Gore & Associates Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499|
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.